ARTICLES BY MATHINI ILANCHERAN
-
![Finance business trade economy-GettyImages-2230458034]( "U.S. Pharma Tariffs And MFN Become Law After April 2 Update")
U.S. Pharma Tariffs And MFN Become Law After April 2 Update4/15/2026Beginning July 31, 2026, a U.S. pharmaceutical tariff will apply to patented products and their APIs, beginning with large companies. Beroe Inc.'s Mathini Ilancheran breaks down the tariff's impact, explores its risks, and proposes five procurement strategies to addressing them.
-
![Various Pills on White Stripes of American Flag-GettyImages-172849908]( "U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact")
U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact2/18/2026Beroe Inc.'s Mathini Ilancheran discusses the 2025 U.S. pharma tariff framework and translates it into actionable procurement and outsourcing responses.
-
![India and us flags-GettyImages-1089423548]( "Global Implications Of Zero Tariffs On Indian Pharma Exports To China")
Global Implications Of Zero Tariffs On Indian Pharma Exports To China11/5/2025Discover the worldwide impacts of China’s zero-tariff policy on Indian pharmaceutical drugs.
-
![Target business strategy and success motivation symbol digital-GettyImages-2190546471]( "Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development")
Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development10/21/2025Discover how partnerships — especially with capable CROs — as well as resilient supply chains, digital enablement, regulatory foresight, and specialized talent impact the success of targeted protein degradation therapies.
